Chiral Technologies is a local subsidiary of Daicel Corporation, the global market leader in enantioselective chromatography, offering the most extensive portfolio of chiral stationary phases available on the market. Scientists in the pharmaceutical, agricultural and food industries, universities and government agencies rely on our expertise in enantioselective chromatography to separate chiral molecules into single enantiomers in research and development departments, QC laboratories and manufacturing. Enantioselective chromatography is essential to accelerate drug discovery and development processes.
